Kenzie Maclsaac
Private Equity Investor bei Cure Ventures Management LP
Aktive Positionen von Kenzie Maclsaac
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Cure Ventures Management LP
 Cure Ventures Management LP Investment ManagersFinance Cure Ventures Management LP (Cure Ventures) is a venture capital firm founded in 2021 by David R Fallace, Richard J Lim and Lou A Tartaglia. The firm is headquartered in Boston, Massachusetts. | Private Equity Investor | 01.03.2022 | - |
Karriereverlauf von Kenzie Maclsaac
Ehemalige bekannte Positionen von Kenzie Maclsaac
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Direktor/Vorstandsmitglied | 01.12.2018 | 03.12.2022 |
Fog Pharmaceuticals, Inc.
 Fog Pharmaceuticals, Inc. BiotechnologyHealth Technology Fog Pharmaceuticals, Inc. develops pharmaceutical products. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | 01.04.2018 | 30.11.2018 |
Ausbildung von Kenzie Maclsaac
| Carleton University | Undergraduate Degree |
| University of Toronto | Graduate Degree |
| Massachusetts Institute of Technology | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Kanada | 3 |
Operativ
| Director/Board Member | 2 |
| Private Equity Investor | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Finance | 3 |
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Cure Ventures Management LP
Cure Ventures Management LP Investment ManagersFinance Cure Ventures Management LP (Cure Ventures) is a venture capital firm founded in 2021 by David R Fallace, Richard J Lim and Lou A Tartaglia. The firm is headquartered in Boston, Massachusetts. | Finance |
Fog Pharmaceuticals, Inc.
Fog Pharmaceuticals, Inc. BiotechnologyHealth Technology Fog Pharmaceuticals, Inc. develops pharmaceutical products. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Kenzie Maclsaac
- Erfahrung
